Since the introduction of insulin almost a century ago, more than 80 peptide drugs have
reached the market for a wide range of diseases, including diabetes, cancer, osteoporosis …

While the global market for peptide/protein-based therapeutics is witnessing significant
growth, the development of peptide drugs remains challenging due to their low oral …

The rising prevalence of multidrug-resistant bacteria is an urgent health crisis that can only
be countered through renewed investment in the discovery and development of antibiotics …

The microorganisms that have developed resistance to available therapeutic agents are
threatening the globe and multidrug resistance among the bacterial pathogens is becoming …

Caves have been an item of amateur and professional exploration for many years. Research
on the karst caves has revealed great diversity of bacteria, algae, and fungi living on stone …

Antimicrobial peptides (AMPs) are widespread in multicellular organisms. These structurally
diverse molecules are produced as the first line of defense against pathogens such as …

Conspectus The rise of multidrug resistant bacteria has significantly compromised our
supply of antibiotics and poses an alarming medical and economic threat to society. To …

Introduction The infections by multidrug-resistant bacteria are a growing threat to human
health, and the efficacy of the available antibiotics is gradually decreasing. As such, new …

Natural product (NP)-based antibiotics have been exploited for more than eighty years and
continue saving uncountable lives every year. However, antimicrobial R&D is inadequate to …

Antibiotic failure is one of the most worrisome threats to global health. Among the new
therapeutic efforts that are being explored, the use of bacteriophages (viruses that kill …